Suppr超能文献

相似文献

1
Dominant lethal pathologies in male mice engineered to contain an X-linked DUX4 transgene.
Cell Rep. 2014 Sep 11;8(5):1484-96. doi: 10.1016/j.celrep.2014.07.056. Epub 2014 Aug 28.
2
Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene.
PLoS Genet. 2010 Oct 28;6(10):e1001181. doi: 10.1371/journal.pgen.1001181.
3
Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD.
PLoS Genet. 2013 Apr;9(4):e1003415. doi: 10.1371/journal.pgen.1003415. Epub 2013 Apr 4.
4
Direct interplay between two candidate genes in FSHD muscular dystrophy.
Hum Mol Genet. 2015 Mar 1;24(5):1256-66. doi: 10.1093/hmg/ddu536. Epub 2014 Oct 17.
7
Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy.
Hum Mol Genet. 2013 Feb 1;22(3):568-77. doi: 10.1093/hmg/dds467. Epub 2012 Oct 29.
8
Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7.
EMBO Mol Med. 2021 Aug 9;13(8):e13695. doi: 10.15252/emmm.202013695. Epub 2021 Jun 21.
9
A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy.
PLoS One. 2018 Feb 7;13(2):e0192657. doi: 10.1371/journal.pone.0192657. eCollection 2018.
10
Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model.
Nat Commun. 2017 Sep 15;8(1):550. doi: 10.1038/s41467-017-00730-1.

引用本文的文献

1
2
Estrogen rescues muscle regeneration impaired by DUX4 in a humanized xenograft mouse model.
Cell Death Dis. 2025 Jul 9;16(1):508. doi: 10.1038/s41419-025-07827-2.
4
Flavones provide resistance to DUX4-induced toxicity via an mTor-independent mechanism.
Cell Death Dis. 2023 Nov 16;14(11):749. doi: 10.1038/s41419-023-06257-2.
5
MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy.
Cell Rep. 2023 Sep 26;42(9):113120. doi: 10.1016/j.celrep.2023.113120. Epub 2023 Sep 12.
6
Molecular and Phenotypic Changes in FLExDUX4 Mice.
J Pers Med. 2023 Jun 25;13(7):1040. doi: 10.3390/jpm13071040.
7
Transplantation of PSC-derived myogenic progenitors counteracts disease phenotypes in FSHD mice.
NPJ Regen Med. 2022 Sep 2;7(1):43. doi: 10.1038/s41536-022-00249-0.
9
DUX4 Role in Normal Physiology and in FSHD Muscular Dystrophy.
Cells. 2021 Nov 26;10(12):3322. doi: 10.3390/cells10123322.
10
RIPK3-mediated cell death is involved in DUX4-mediated toxicity in facioscapulohumeral dystrophy.
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):2079-2090. doi: 10.1002/jcsm.12813. Epub 2021 Oct 22.

本文引用的文献

1
Clinical and genetic features of hearing loss in facioscapulohumeral muscular dystrophy.
Neurology. 2013 Oct 15;81(16):1374-7. doi: 10.1212/WNL.0b013e3182a84140. Epub 2013 Sep 16.
2
Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells.
Hum Mol Genet. 2013 Dec 1;22(23):4661-72. doi: 10.1093/hmg/ddt314. Epub 2013 Jul 2.
4
Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD.
PLoS Genet. 2013 Apr;9(4):e1003415. doi: 10.1371/journal.pgen.1003415. Epub 2013 Apr 4.
6
Infantile facioscapulohumeral muscular dystrophy revisited: Expansion of clinical phenotypes in patients with a very short EcoRI fragment.
Neuromuscul Disord. 2013 Apr;23(4):298-305. doi: 10.1016/j.nmd.2013.01.005. Epub 2013 Feb 21.
7
A focal domain of extreme demethylation within D4Z4 in FSHD2.
Neurology. 2013 Jan 22;80(4):392-9. doi: 10.1212/WNL.0b013e31827f075c. Epub 2013 Jan 2.
8
DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy?
J Cell Mol Med. 2013 Jan;17(1):76-89. doi: 10.1111/j.1582-4934.2012.01647.x. Epub 2012 Dec 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验